VANTAGE CONSULTING GROUP INC – Regeneron Pharmaceuticals, Inc. Transaction History
VANTAGE CONSULTING GROUP INC portfolio value:
$247,000
portfolio value
VANTAGE CONSULTING GROUP INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -15.53% | -66 shares | -4K | $688.87 | 359 |
| Q2 2022 | share | Increase | +18.38% | 66 shares | 0 | $591.13 | 425 |
| Q1 2022 | share | Decrease | -7.95% | -31 shares | 5K | $698.42 | 359 |
| Q4 2021 | share | Increase | +4.00% | 15 shares | 19K | $642.51 | 390 |
| Q3 2021 | share | Decrease | -11.56% | -49 shares | -10K | $605.18 | 375 |
| Q2 2021 | share | Increase | 0.00% | 424 shares | 237K | $558.54 | 424 |
| Q1 2021 | share | Decrease | -100.00% | -153 shares | -74K | $473.14 | 0 |
| Q4 2020 | share | Increase | 0.00% | 153 shares | 74K | $483.11 | 153 |